1Alain P. et al.Mouse NK1. 1+T cells∶a new family of T cells[].Immunology Today.1996
2Bendelac A,et al.Mouse NK1 + T cells[].Current Opinion in Immunology.1995
3Perk S. H,et al.Tissue-Specific Recognition of Mouse CD1 Molecule[].J Immunol.1998
4Trauth N. N. et al.An interleukin 4 (IL4) -independent pathway for CD4+T cell IL-4 production is revealed in IL-4 receptor-deficient mice[].Proceedings of the National Academy of Sciences of the United States of America.1997
5Smiley S. T. et al.Immunoglobulin E production in the absence of interleukdin-4-secreting CD1-dependent cells[].Science.1997
6Nishizawa k. et al.IL-2 and IL-7 differentially induce CD4-CD8-αβTCR NK1. 1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8-αβTCR NK1. 1-cells∶implications for the regulation of Th1-and Th2-type responses[].International Immunology.1997
7Kawano T. et al.Natura killer-like nonspecific tumor cell lysis mediated by spceific ligand-activated V a 14 NKT cells[].Proceedings of the National Academy of Sciences of the United States of America.1998
8Emoto M.et al.TCR-mediated target cell lysis by CD4 + NK1 +liver T lymphocytes[].International Immunology.1997
9Kawamura T.etal.Critical role of NK1 +T cells in IL- 12- induced immune responses in vivo[].JImmunol.1998
10Sdei S. et al.Antimetastatic effect of NK1+T cells on experimental haematogeneous tumor metases in the liver and lungs of mice[].Immunology Today.1997
同被引文献20
1DUTHIE M S, KAHN M, WHITE M, et al. Both CD1d antigen presentation and interleukin - 12 are required to activate natural killer T cells during turpanosoma cmzi infection [ J ] .Infect immun, 2005, 73(3) : 1890-1894
2WESLEY J D, BOBBINS S H, SIDOBBE S, et al.Cutting edge: IFN - γ gamma singnaling to macrophages is required for optimal Va14 NKT/NK cell cross-talk [J] . J Immunol, 2005, 174 (4): 3864 - 3868
3BEZBRADICA J S, STANIC A K, MATSUKI N,et al. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cells activation in vivo [ J ].Immunol, 2005, 174 (8) : 4705
4OKI S, CHIBA A, YAMAMURA T, et al, The clinical implication and molecular mechanism of preferential Ⅱ -4 production by modified glycolipid - stimulated NKT cells[J].J Clin Invest, 2004, 113 (11) :1631 -1640
5YU KOA, IM J S, MOLANNO A, et al.Modulation of CD1d- restricted NKT cell responses by using N -acyl variants of a - galactosylceramides [ J ] . Proc Natl Acad Sci USA, 2005, 102 (9) : 3333 -3338
6CHEN Y G, MORGANE C, THOMAS M, et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic ceils to pancreatic lymph nodes [J].J Immunol, 2005, 174 (3):1196 - 1204
7BEZINS S P, KYPARISSOUDIS K, PELLICCI D G,et al. Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood : implications for human studies[ J ].J Immunol Cell Biol, 2004, 82(3) : 247 -252
8KIM H Y, KIM H J, MIN H S, et al. NKT cells promote antibody induced joint inflammation by suppressing transforming growth factor production[ J ], J Exp Med, 2005, 201 (1): 41-47
9HAYAKAWA Y, TAKE DA K, YAGITA H, et al.Differential regulation of Thl and Th2 function of NKT cells by CD28 and CD40 cosfimulatory pathways[ J ].J Immunol, 2001, 166 (8) : 6012
10SHIN- ICHIRO F K, SHIMIZU C, SRITH L, et al.STEINMAN. Activation of natural killer T cells by a -galactosylceramide rapidly induces full maturation of dendritic cells in vivo and thereby acts as an adjuvan tfor combined CD4 and CD8 T cell immunity to a coadministered protein[ J ] . J Exp Med, 2003, 198(1): 267
